COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

ADVM-022 Intravitreal Gene Therapy for Wet AMD (OPTIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03748784
Recruitment Status : Active, not recruiting
First Posted : November 21, 2018
Last Update Posted : November 23, 2020
Information provided by (Responsible Party):
Adverum Biotechnologies, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 2022
Estimated Study Completion Date : June 2022